A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

The Hims & Hers planned Super Bowl ad buy – and the content of that ad – is noteworthy, but not because it violates any regulations. Indeed, the ad generally complies with federal law and U.S. Food ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

The FDA will allow two biotechnology companies to run clinical trials: United Therapeutics and eGenesis. United Therapeutics ...

The ad violates federal rules requiring “that advertising for prescription drugs – including compounded drugs – not be false ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Symbravo (meloxicam and ...

Susvimo is the first and only FDA-approved treatment shown to maintain vision in people with diabetic macular edema with ...

Dr. Tycel Phillips discusses the FDA approval of a Calquence combo in MCL, making it the first and only BTK inhibitor ...